LncRNA-NEF is downregulated in postmenopausal osteoporosis and is related to course of treatment and recurrence

LncRNA-NEF antagonized epithelial to mesenchymal transition and cancer metastasis via cis-regulating FOXA2 and inactivating Wnt/β-catenin signaling

(2018) Wei-Cheng Liang et al.   ONCOGENE

Screening for osteoporosis in Chinese post-menopausal women: a health economic modelling study

(2016) L. Si et al.   OSTEOPOROSIS INTERNATIONAL

Postmenopausal osteoporosis

(2016) Richard Eastell et al.   Nature Reviews Disease Primers

Management of Postmenopausal Osteoporosis

(2015) Panagiota Andreopoulou et al.   Annual Review of Medicine

Long non-coding RNA-DANCR in human circulating monocytes: a potential biomarker associated with postmenopausal osteoporosis

(2015) Xiang Tong et al.   BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY

Osteoporosis: the evolution of a diagnosis

(2015) M. Lorentzon et al.   JOURNAL OF INTERNAL MEDICINE

An overview on the treatment of postmenopausal osteoporosis

(2014) Sergio Setsuo Maeda et al.   Arquivos Brasileiros de Endocrinologia e Metabologia

Long non-coding RNAs: A new frontier in the study of human diseases

(2013) Xuefei Shi et al.   CANCER LETTERS

Immune Regulation of Osteoclast Function in Postmenopausal Osteoporosis: A Critical Interdisciplinary Perspective

(2012) Renqing Zhao   International Journal of Medical Sciences

Long noncoding RNAs and human disease

(2011) Orly Wapinski et al.   TRENDS IN CELL BIOLOGY

Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis

(2010) Roberto Pacifici   JOURNAL OF BONE AND MINERAL RESEARCH

Long non-coding RNAs: insights into functions

(2009) Tim R. Mercer et al.   NATURE REVIEWS GENETICS